Lyndie Hughes
Medical · Patchogue, NYNPI 1780838862
Payments from drug & device makers
Across 259 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$785
- Amgen$575
- AbbVie$552
- GSK$490
- Novo Nordisk$453
- Pfizer$402
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,035100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $785 |
| Amgen | 23 | $575 |
| AbbVie | 28 | $552 |
| GSK | 24 | $490 |
| Novo Nordisk | 25 | $453 |
| Pfizer | 20 | $402 |
| Lilly USA, LLC | 19 | $391 |
| Boehringer Ingelheim | 19 | $361 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $270 |
| Astellas Pharma US Inc | 7 | $149 |
| Amarin Pharma, Inc. | 6 | $99 |
| Merck | 6 | $93 |
| Redhill Biopharma Inc. | 5 | $87 |
| Kowa Pharmaceuticals America, Inc. | 5 | $72 |
| Johnson & Johnson | 3 | $46 |
| Eisai Inc. | 2 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Bausch Health US, LLC | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Neos Therapeutics, LP | 1 | $15 |
How this compares
$5,051 in reported general payments places this provider in the 90th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 56 | $90,894 |
| JardianceEmpagliflozin | 34 | $52,649 |
| OzempicSemaglutide | 27 | $49,050 |
| EliquisApixaban | 38 | $41,544 |
| TrulicityDulaglutide | 15 | $33,457 |
| XareltoRivaroxaban | 13 | $20,932 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $19,109 |
| Lagevrio (Eua)Molnupiravir | 20 | $6,793 |
| LivaloPitavastatin Calcium | 14 | $4,430 |
| SynthroidLevothyroxine Sodium | 57 | $3,235 |
| Metoprolol Succinate | 186 | $3,185 |
| Levothyroxine Sodium | 210 | $3,165 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $2,988 |
| Rosuvastatin Calcium | 194 | $2,780 |
| Pitavastatin Calcium | 15 | $2,326 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $391 | $124,35071 claims |
| Boehringer IngelheimJardiance | $361 | $52,64934 claims |
| Novo NordiskOzempic | $453 | $49,05027 claims |
| PfizerEliquis | $402 | $41,54438 claims |
| Johnson & JohnsonXarelto | $46 | $20,93213 claims |
| GSKTrelegy Ellipta | $490 | $19,10911 claims |
| MerckLagevrio (Eua) | $93 | $6,79320 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $72 | $4,43014 claims |
| AbbVieSynthroid | $552 | $3,23557 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,395 medical providers in New York.
Other medical in Patchogue
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.